Srinivas Akkaraju bought $1.2M of KLRS stock

Srinivas Akkaraju, Dir, 10% of Kalaris Therapeutics, Inc. (KLRS), bought 244,300 shares of KLRS stock worth $1.2M, per an SEC Form 4 filed May 22, 2026.

The shares came through a private deal, not the open market.

The trade happened on May 20, 2026, 2 days before it was made public.

KLRS has moved -65.6% since the trade date, from $4.83 to $1.66 (Nov 12, 2026 close).